Poulain D, Fruit J, Fournier L, Masson F, Dei-Cas E, Vernes A
Ann Biol Clin (Paris). 1986;44(3):225-32.
We have previously described a co-immunofiltration reaction which identifies a specific precipitating system (SPCS) in sera from patients presenting systemic candidiasis. The SPCS is characterized by coalescence with an experimental serum directed against the germinative tubes of Candida albicans. The present study concerns our experience of the use of co-immunofiltration in routine hospital practice. Complete observations involving clinical, mycological and serologic data were selected in order to illustrate various possible developmental trends for SPCS during candidiasis. The SPCS usually develops early infections due to the yeast species most frequently implicated in hospital pathologies; an increase in its intensity reflects a developing infection or the start of therapy. The SPCS disappears slowly and gradually when infectious development is favorable, but its sudden disappearance represents an unfavorable prognosis correlated with detection of circulating antigens. Circulating antigens are also seen in severe cases of candidiasis in which the SPCS is not present. Indeed there is a certain complementarity between these two observations.
我们之前描述过一种联合免疫过滤反应,该反应可识别系统性念珠菌病患者血清中的一种特定沉淀系统(SPCS)。SPCS的特征是与针对白色念珠菌发芽管的实验血清凝聚。本研究涉及我们在医院常规实践中使用联合免疫过滤的经验。选取了包含临床、真菌学和血清学数据的完整观察结果,以说明念珠菌病期间SPCS的各种可能发展趋势。SPCS通常在医院病理中最常涉及的酵母菌种引起的早期感染时出现;其强度增加反映感染进展或治疗开始。当感染发展有利时,SPCS会缓慢逐渐消失,但其突然消失代表与循环抗原检测相关的不良预后。在不存在SPCS的严重念珠菌病病例中也可见循环抗原。事实上,这两种观察结果之间存在一定的互补性。